MPG.eBooks - Description: Aripiprazole for patients with bipolar disorder

Cover Image

Read Now

Aripiprazole for patients with bipolar disorder a review of the clinical effectiveness, cost-effectiveness, and guidelines

This Rapid Response report aims to review the clinical and cost-effectiveness of aripiprazole for patients with bipolar disorder. Guidelines associated with the use of aripiprazole for patients with bipolar disorder will also be examined

Bibliographic Details
Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2016, 25 May 2016
Series:	Rapid response report: summary with critical appraisal
Subjects:	Cost-benefit Analysis Treatment Outcome Aripiprazole / Therapeutic Use Guidelines As Topic Bipolar Disorder / Drug Therapy
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK368301
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	This Rapid Response report aims to review the clinical and cost-effectiveness of aripiprazole for patients with bipolar disorder. Guidelines associated with the use of aripiprazole for patients with bipolar disorder will also be examined
Item Description:	"CADTH Rapid Response Service."
Physical Description:	1 PDF file (20 pages) illustration